Journal of applied clinical medical physics · 2025
Residual range-based quenching correction for Gafchromic EBT3 film in proton therapy patient-specific QA.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin Ting-Chun, Hsu Hsiu-Ting, Chen Yu-Fen, Chiou Yu-Rou, Liang Ji-An, Shiau An-Cheng
Аннотация
BACKGROUND: Gafchromic EBT3 film is a widely used dosimeter in radiotherapy due to its high spatial resolution and near tissue equivalence. However, its application in proton therapy is limited by the linear energy transfer (LET) quenching effect, particularly in the Bragg peak region.
PURPOSE: This study proposes a correction method based on residual range (Rres) to quantify and mitigate this quenching effect for improved accuracy in patient-specific quality assurance (PSQA) and related research.
METHODS: We defined a quenching factor (QF) as the ratio of dose measured with a Markus ionization chamber to that measured with EBT3 film. The EBT film calibration curve is established by measurements in the plateau region of the depth-dose distribution of a monoenergetic proton reference beam. A series of proton treatment plans with varying spread-out Bragg peaks (SOBPs) were designed to examine QF across different residual ranges. A correction function correlating Rres to QF was derived. Clinical verifications of patient-specific QA were performed by comparing EBT3 measurements, with and without QF correction, to MatriXX-PT and Eclipse TPS calculations.
RESULTS: The EBT3 film underestimated dose by approximately 7% at an Rres of 1.4 cm. A clear dependence of film response on Rres was observed: as Rres decreased, the degree of under-response increased. A correction function was established based on the relationship between Rres and QF, enabling accurate dose reconstruction. The dose map measured using QF-calibrated EBT3 film showed good agreement with the TPS-calculated data, and the discrepancies between the EBT3 film measurements, MatriXX-PT measurements, and TPS calculations were significantly reduced in regions with smaller Rres values.
CONCLUSION: We proposed and validated a clinically applicable correction function for EBT3 film quenching in proton PSQA. This approach offers a practical and cost-effective solution for both clinical and research applications involving proton dosimetry.
PURPOSE: This study proposes a correction method based on residual range (Rres) to quantify and mitigate this quenching effect for improved accuracy in patient-specific quality assurance (PSQA) and related research.
METHODS: We defined a quenching factor (QF) as the ratio of dose measured with a Markus ionization chamber to that measured with EBT3 film. The EBT film calibration curve is established by measurements in the plateau region of the depth-dose distribution of a monoenergetic proton reference beam. A series of proton treatment plans with varying spread-out Bragg peaks (SOBPs) were designed to examine QF across different residual ranges. A correction function correlating Rres to QF was derived. Clinical verifications of patient-specific QA were performed by comparing EBT3 measurements, with and without QF correction, to MatriXX-PT and Eclipse TPS calculations.
RESULTS: The EBT3 film underestimated dose by approximately 7% at an Rres of 1.4 cm. A clear dependence of film response on Rres was observed: as Rres decreased, the degree of under-response increased. A correction function was established based on the relationship between Rres and QF, enabling accurate dose reconstruction. The dose map measured using QF-calibrated EBT3 film showed good agreement with the TPS-calculated data, and the discrepancies between the EBT3 film measurements, MatriXX-PT measurements, and TPS calculations were significantly reduced in regions with smaller Rres values.
CONCLUSION: We proposed and validated a clinically applicable correction function for EBT3 film quenching in proton PSQA. This approach offers a practical and cost-effective solution for both clinical and research applications involving proton dosimetry.